Interbreeding with Neanderthals may be responsible for modern-day brain condition, SFU study finds
Peer-Reviewed Publication
Updates every hour. Last Updated: 19-Oct-2025 14:11 ET (19-Oct-2025 18:11 GMT/UTC)
A new Simon Fraser University-led study reveals interbreeding between humans and their ancient cousins, Neanderthals, as the likely origin of a neurological condition estimated to impact up to one per cent of people today.
The study, published this week in the journal Evolution, Medicine, and Public Health, was led by Kimberly Plomp, a recent postdoctoral fellow at SFU and Mark Collard, the Canada Research Chair in Human Evolutionary Studies and a professor in the Department of Archaeology. Their findings suggest that Chiari Malformation Type 1, a serious and sometimes fatal neurological condition, may be linked to Neanderthal genes that entered the human gene pool through interbreeding tens of thousands of years ago.
Birds have developed a unique evolutionary solution to ensure the survival of males – a powerful microRNA. This tiny gene allows male embryos to survive despite a genetic imbalance between the sexes by balancing the activity of the sex chromosomes. An international research team led by biologists from Heidelberg University and the University of Edinburgh (Scotland) has discovered this previously unknown mechanism, which differs significantly from the system that mammals have developed in the course of evolution to address the same biological challenge.
A popular species of edible mushroom, golden oyster, has spread rapidly throughout the United States since escaping from cultivation into the wild. Now, a new study from researchers at the University of Wisconsin–Madison shows these mushrooms are spreading in every direction from their initial documented escapes in New York, Iowa, Wisconsin and Ohio. The study, published in the journal Current Biology, also found that ecosystems invaded by the golden oyster support less diversity of fungal species and smaller numbers of native fungal species.
A new experimental design framework could enable scientists to efficiently estimate how combinations of interventions will affect a group of cells, reducing the cost of experiments and providing less biased data that could be used to understand disease mechanisms or develop new treatments.